<SEC-DOCUMENT>0001104659-25-087076.txt : 20250903
<SEC-HEADER>0001104659-25-087076.hdr.sgml : 20250903
<ACCEPTANCE-DATETIME>20250903164105
ACCESSION NUMBER:		0001104659-25-087076
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250829
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250903
DATE AS OF CHANGE:		20250903

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVADEL PHARMACEUTICALS PLC
		CENTRAL INDEX KEY:			0001012477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37977
		FILM NUMBER:		251290401

	BUSINESS ADDRESS:	
		STREET 1:		BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
		STREET 2:		BALLYCOOLIN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			15
		BUSINESS PHONE:		636-449-1830

	MAIL ADDRESS:	
		STREET 1:		16640 CHESTERFIELD GROVE ROAD
		STREET 2:		SUITE 200
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLAMEL TECHNOLOGIES SA
		DATE OF NAME CHANGE:	19960422
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2525099d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:avdl="http://avadel.com/20250829">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_avdl_avadel.com_20250829 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20250829_20250829 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001012477 -->
<!-- Field: Set; Name: xdx; ID: xdx_071_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\EntityInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000004" name="dei:EntityCentralIndexKey">0001012477</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="avdl-20250829.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-29</xbrli:startDate>
        <xbrli:endDate>2025-08-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>FORM <span id="xdx_90C_edei--DocumentType_c20250829__20250829_zTUZykEHldP"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span style="font-size: 10pt">Pursuant
to Section 13 or Section 15(d)</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span style="font-size: 10pt">of the Securities Exchange Act of 1934</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Date of Report
(Date of earliest event reported)</b>: <span id="xdx_90D_edei--DocumentPeriodEndDate_c20250829__20250829_zhA2DLJEULAh"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">August 29, 2025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20250829__20250829_z1betjGwrgeg"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000012" name="dei:EntityRegistrantName">AVADEL PHARMACEUTICALS PLC</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Exact name of registrant as specified
in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250829__20250829_z98GffHGJYX3"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:edgarprovcountryen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Ireland</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20250829__20250829_zo6PPqzFzL1b"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000014" name="dei:EntityFileNumber">001-37977</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20250829__20250829_zUQTmGLDqlrj"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000015" name="dei:EntityTaxIdentificationNumber">98-1341933</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(Commission</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(IRS Employer</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">of incorporation)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">File Number)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_900_edei--EntityAddressAddressLine1_c20250829__20250829_zXgJAfLQtZ41"><b><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000016" name="dei:EntityAddressAddressLine1">10
        Earlsfort Terrace</ix:nonNumeric></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressCityOrTown_c20250829__20250829_zdnXPN7TSUp8"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000017" name="dei:EntityAddressCityOrTown">Dublin 2</ix:nonNumeric></span></b>, <b><span id="xdx_909_edei--EntityAddressCountry_c20250829__20250829_zvgeUvEn0WCh"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:countrynameen" id="Fact000018" name="dei:EntityAddressCountry">Ireland</ix:nonNumeric></span>,</b><b> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20250829__20250829_z1OXVR8oMlgb"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000019" name="dei:EntityAddressPostalZipCode">D02
T380</ix:nonNumeric></span></b></p></td>
    <td style="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; width: 50%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Not Applicable</b></p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code</b><span style="font-style: normal">:</span> <b>+<span id="xdx_901_edei--CityAreaCode_c20250829__20250829_zu5rypq6SBPd"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000020" name="dei:CityAreaCode">353</ix:nonNumeric> </span></b><b><span id="xdx_903_edei--LocalPhoneNumber_c20250829__20250829_z1p5nlZbxpZd"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000021" name="dei:LocalPhoneNumber">1
901-5201</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address,
if changed since last report)</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation      of the registrant under any of the following provisions:</p>

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20250829__20250829_zYx1mP0ZEAkl"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_907_edei--SolicitingMaterial_c20250829__20250829_zYmqZml4Wwmd"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20250829__20250829_zmUbL9eabVfl"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20250829__20250829_zpZnC788NTua"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 7pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 1pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="text-align: left; vertical-align: bottom">
    <td style="border: Black 1pt solid; width: 40%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 40%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">Name of each exchange on which <br/>
registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--Security12bTitle_c20250829__20250829_zRXhmTYFPNTi"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000026" name="dei:Security12bTitle">Ordinary
Shares, nominal value $0.01 per share</ix:nonNumeric></span></p></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20250829__20250829_z5j4FYIjY9Vg"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000027" name="dei:TradingSymbol">AVDL</ix:nonNumeric></span></p></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--SecurityExchangeName_c20250829__20250829_zm6SMoqpYxgh"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Global Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20250829__20250829_zXmhyC8xKYW5"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01. Entry into a Material Definitive Agreement. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 29, 2025, Avadel Pharmaceuticals plc (the &#8220;Company&#8221;)
entered into an exclusive global license agreement (the &#8220;License Agreement&#8221;) with XWPharma Ltd. (&#8220;XWPharma&#8221;) for
the development and commercialization of valiloxybate, a GABA<sub>B</sub> receptor agonist, in all indications, including the treatment
of sleep disorders, such as narcolepsy and idiopathic hypersomnia (&#8220;IH&#8221;). Under the terms of the License Agreement, XWPharma
grants the Company an exclusive global license to develop, manufacture and commercialize valiloxybate worldwide, excluding mainland China,
Hong Kong and Macau.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">XWPharma received an upfront payment of
$15 million to date and will receive an additional upfront payment of $5 million from the Company in the fourth quarter of 2025.
XWPharma is eligible to receive milestone payments associated with certain development milestones of up to $30 million. The Company
 also agreed to pay XWPharma up to an aggregate of $155 million in performance-based tiered sales milestones for first
achievement of annual net sales up to $750 million. For first achievement of annual net sales exceeding $750 million and up to $3.5
billion, the Company will pay XWPharma certain performance-based sales milestone payments equal to 10% of each of those sales
milestones. In addition, the Company agreed to pay tiered royalties ranging from high-single digit to mid-teens, as a percentage of
annual net sales of the licensed products, and also an additional $10 million milestone payment after the first
commercial sale in the U.S. for each indication beyond narcolepsy and IH following the U.S. Food and Drug Administration&#8217;s
approval for same.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Unless earlier terminated, the term of the
License Agreement will continue until expiration of the last royalty term for the applicable product in the applicable country. The License
Agreement is subject to customary termination provisions, including termination by a party for the other party&#8217;s uncured, material
breach. Additionally, subject to a notice period, the Company may terminate the License Agreement for convenience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The License Agreement also includes customary
representations and warranties, covenants and indemnification obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing summary of the terms of the License Agreement is qualified
in its entirety by reference to the full text of the License Agreement, a copy of which the Company intends to file as an exhibit to its
Quarterly Report on Form 10-Q for the quarter ending September 30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01. Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 3, 2025, the Company issued a press release entitled &#8220;Avadel
Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd.&#8221; A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on the Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information in this Item 7.01, including Exhibit 99.1 attached
hereto, is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth
by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cautionary Disclosure Regarding&#160;Forward-Looking&#160;Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Current Report on Form 8-K includes &#8220;forward-looking&#160;statements&#8221;
within the meaning of Section 27A of the&#160;Securities Act of 1933&#160;and Section 21E of the&#160;Securities Exchange Act of 1934.
These&#160;forward-looking&#160;statements relate to our future expectations, beliefs, plans, strategies, objectives, results, conditions,
financial performance, prospects or other events. Such&#160;forward-looking&#160;statements include, but are not limited to, statements
regarding the Company&#8217;s expectations about the License Agreement, including upfront, milestone and royalty payments. In some cases,&#160;forward-looking&#160;statements
can be identified by the use of words such as &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221;
&#8220;look forward,&#8221; &#8220;on track,&#8221; &#8220;guidance,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221;
&#8220;next steps&#8221; and similar expressions and the negatives thereof (if applicable).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#8217;s&#160;forward-looking&#160;statements are based
on estimates and assumptions that are made within the bounds of our knowledge of our business and operations and that we consider reasonable.
However, the Company&#8217;s business and operations are subject to significant risks, and, as a result, there can be no assurance that
actual results and the results of the company&#8217;s business and operations will not differ materially from the results contemplated
in such&#160;forward-looking&#160;statements. Factors that could cause actual results to differ from expectations in the Company&#8217;s&#160;forward-looking&#160;statements
include the risks and uncertainties described in the &#8220;Risk Factors&#8221; section of Part I, Item 1A of the Company&#8217;s Annual
Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission (SEC) on March 3,
2025, and subsequent SEC filings.&#160;Forward-looking&#160;statements speak only as of the date they are made and are not guarantees
of future performance. Accordingly, you should not place undue reliance on&#160;forward-looking&#160;statements. The Company does not
undertake any obligation to publicly update or revise our&#160;forward-looking&#160;statements, except as required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item 9.01.</b> <b>Exhibits</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; font-size: 10pt; text-underline-color: #000000; text-indent: -10pt"><a href="tm2525099d1_ex99-1.htm" style="-sec-extract: exhibit">99.1</a></td>
    <td style="padding-left: 10pt; font-size: 10pt; text-underline-color: #000000; text-indent: -10pt"><a href="tm2525099d1_ex99-1.htm" style="-sec-extract: exhibit">Press release issued by Avadel
    Pharmaceuticals plc on September 3, 2025.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; font-size: 10pt; text-underline-color: #000000; text-indent: -10pt">104</td>
    <td style="padding-left: 10pt; font-size: 10pt; text-underline-color: #000000; text-indent: -10pt">Cover Page Interactive Data File
    (embedded with the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font-size: 10pt"><b>AVADEL PHARMACEUTICALS PLC</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">By: </span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><span style="font-size: 10pt">/s/ Jerad G. Seurer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; width: 50%"><span style="font-size: 10pt">Date: September 3, 2025</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">Name: </span></td>
    <td style="width: 42%"><span style="font-size: 10pt">Jerad G. Seurer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">General Counsel &amp; Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WUrFfPAxMYksRCJ6XXKMJd2R2c3qk/rLNiUaBobh3nOvEL4oaKM6ZDiv6xKO2A+dtAg1tsioL+gc2XaXgrs1XpWxLLWd3h+YkWPQMatFFEsnTNZRGWxSCINlmCyjGIIwjROo9sL76hnpVjWorZIdSN1AxTSwQiv5NScc5ZM09a+p6oRsFGkXtwhm+Q1REEZwoFE+iG8GyjITnj+NJwqm++Bc+dOi/pKQd9i7OjPT//U+BuZKjQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2525099d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit&nbsp;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2525099d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Avadel Pharmaceuticals
Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>&ndash; Expands Avadel&rsquo;s
pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia &ndash;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>&ndash; Initial pharmacokinetic
(PK) and comparative bioavailability study to initiate in fourth quarter 2025 with pivotal PK trial planned for second half 2026 &ndash;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>&ndash; XWPharma to
receive $20 million upfront; potential for development, regulatory and sales milestone payments in addition to royalties on future
net sales &ndash;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DUBLIN,&nbsp;Ireland&nbsp;&amp;
REDWOOD CITY, Calif., September&nbsp;3, 2025</B></FONT> - Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused
on transforming medicines to transform lives, and XWPharma Ltd. (&ldquo;XWPharma&rdquo;) together announced today that Avadel has entered
into an exclusive global license agreement with XWPharma to develop and commercialize valiloxybate, a GABA<SUB>B</SUB> receptor agonist,
for all indications, including the treatment of sleep disorders, such as narcolepsy and idiopathic hypersomnia (&ldquo;IH&rdquo;). Valiloxybate
has been purposefully designed to deliver the therapeutic benefits of oxybate therapy through a once-at-bedtime, salt-free and artificial sweetener-free formulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&quot;The addition of valiloxybate, the only
once-at-bedtime, salt-free and artificial sweetener-free, extended-release oxybate, into our portfolio further reflects Avadel&rsquo;s position
as a leader in sleep medicine,&rdquo; said Greg Divis, Chief Executive Officer of Avadel Pharmaceuticals. &ldquo;The broad adoption of
LUMRYZ demonstrates the transformative benefits that a once-at-bedtime oxybate therapy can bring to patients and their families. As an
innovator in the treatment of sleep disorders, we are excited to add valiloxybate to our pipeline.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;We are pleased to enter into this
licensing agreement with Avadel, a recognized leader in the clinical and commercial advancement of once-at-bedtime oxybate therapy and
the ideal partner to progress valiloxybate to market,&rdquo; said James Huang, Executive Chairman of XWPharma. &ldquo;We are excited
for the opportunity to offer access to this innovative therapy to a broad population of those living with sleep disorders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;I am thrilled that Avadel is continuing to advance its mission
to improve the lives of those living with hypersomnolence disorders by building on the team&rsquo;s expertise in innovation and novel
drug delivery system development,&rdquo; said Anne Marie Morse, D.O., Director of Pediatric Neurology at&nbsp;Geisinger Medical Center&nbsp;at
Janet Weis Children&rsquo;s Hospital. &ldquo;The plans to develop valiloxybate for the treatment of narcolepsy and IH with a once at
nighttime medication delivery system grows our ability to reach and personalize care for more individuals living with these conditions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Oxybates are transformational medications for people living
with narcolepsy and IH, as they provide proven durable efficacy and address the 24 hour a day nature of these disorders. While sodium
sensitivity can affect a small proportion of these patients, all patients deserve the benefit of personalized care and the option of
a no sodium once at bedtime dosing solution. I believe the additional option of once at bedtime no sodium valiloxybate will further expand
utilization and, most importantly, benefit more patients,&rdquo; continued Dr.&nbsp;Morse.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2525099d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About the Licensing Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Under the terms of the agreement, XWPharma
grants Avadel an exclusive global license to develop, manufacture and commercialize valiloxybate worldwide, excluding mainland China,
Hong Kong, and Macau. XWPharma will receive an upfront payment of $20 million from Avadel and is eligible to receive milestone payments
associated with certain development milestones of up to $30 million. Avadel has also agreed to pay XWPharma up to an aggregate of $155
million in performance-based tiered sales milestones for first achievement of annual net sales up to $750 million. For first achievement
of annual net sales exceeding $750 million and up to $3.5 billion, Avadel will pay XWPharma certain performance-based sales milestone
payments equal to 10% of each of those sales milestones. In addition, Avadel has agreed to pay tiered royalties ranging from high-single digit
to mid-teens, as a percentage of net sales of the licensed products, and also an additional $10 million milestone
payment after the first commercial sale in the U.S. for each indication beyond narcolepsy and IH following FDA approval for same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Avadel expects to advance its valiloxybate
formulation into an initial PK study in the fourth quarter of 2025, followed by a pivotal PK trial in the second half of 2026. The program
is expected to benefit from Avadel&rsquo;s existing infrastructure and commercial capabilities, potentially allowing for efficient clinical
and regulatory advancement via a bioequivalence pathway as well as a streamlined commercial launch, if approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>About Valiloxybate</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Valiloxybate is a GABA<SUB>B</SUB> receptor
agonist, designed to deliver the therapeutic benefits of oxybate therapy through a once-at-bedtime, salt-free and artificial sweetener-free formulation. The molecule&rsquo;s properties enable extended-release delivery, offering a potentially differentiated profile from traditional
oxybate therapies. Importantly, preliminary clinical data suggest the potential for bioequivalence to be established between valiloxybate
and Avadel&rsquo;s LUMRYZ, the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness (EDS) in patients
seven years of age and older with narcolepsy. Accordingly, successful completion of the PK clinical program and FDA alignment with our
regulatory approach could potentially result in a streamlined and capital-efficient development pathway for valiloxybate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>About LUMRYZ&trade; (sodium
oxybate) for extended-release oral suspension</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">LUMRYZ is an extended-release
sodium oxybate medication approved by the FDA on May&nbsp;1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive
daytime sleepiness (EDS) in adults with narcolepsy. On October&nbsp;16, 2024, LUMRYZ was additionally approved as a once-at-bedtime treatment
for cataplexy or EDS in pediatric patients seven years of age and older with narcolepsy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The FDA approval of LUMRYZ was
supported by results from REST-ON&trade;, a randomized, double-blind, placebo-controlled, pivotal Phase 3 trial in adults with narcolepsy.
LUMRYZ demonstrated statistically significant and clinically meaningful improvements in the three co-primary endpoints: EDS (MWT), clinicians&rsquo;
overall assessment of patients&rsquo; functioning (CGI-I), and cataplexy attacks, for all three evaluated doses when compared to placebo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2525099d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">With its approvals in May&nbsp;2023
and October&nbsp;2024, the FDA also granted seven years of Orphan Drug Exclusivity to LUMRYZ for the treatment of cataplexy or EDS in
adults with narcolepsy and in pediatric patients seven years of age and older with narcolepsy respectively due to a finding of clinical
superiority of LUMRYZ relative to currently available oxybate treatments. In particular, the FDA found that LUMRYZ makes a major contribution
to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal
arousal to take a second dose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">LUMRYZ is only currently approved
for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy, and Avadel does not sell LUMRYZ for any
indication beyond narcolepsy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>INDICATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">LUMRYZ&nbsp;(sodium
oxybate) for extended-release oral suspension is a prescription medicine used to treat the following symptoms in patients seven years
of age and older with narcolepsy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>sudden
                                            onset of weak or paralyzed muscles (cataplexy)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>excessive daytime
                                            sleepiness (EDS) </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IMPORTANT SAFETY INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARNING: Taking LUMRYZ&trade; (sodium oxybate)
    with other central nervous system (CNS) depressants, such as medicines used to make you fall asleep, including opioid analgesics,
    benzodiazepines, sedating antidepressants, antipsychotics, sedating anti-epileptic medicines, general anesthetics, muscle relaxants,
    alcohol or street drugs, may cause serious medical problems, including trouble breathing (respiratory depression), low blood pressure
    (hypotension), changes in alertness (drowsiness), fainting (syncope) and death.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The active ingredient of LUMRYZ (sodium
    oxybate) is a form of gamma hydroxybutyrate (GHB), a controlled substance. Abuse or misuse of illegal GHB alone or with other CNS
    depressants (drugs that cause changes in alertness or consciousness) have caused serious side effects. These effects include seizures,
    trouble breathing (respiratory depression), changes in alertness (drowsiness), coma and death. Call your doctor right away if you
    have any of these serious side effects.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Because of these risks, LUMRYZ is available
    only by prescription and filled through certified pharmacies in the LUMRYZ REMS. You must be enrolled in the LUMRYZ REMS to receive
    LUMRYZ. Further information is available at www.LUMRYZREMS.com or by calling 1-877-453-1029.</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Do not
take LUMRYZ if you take or your child takes </B></FONT>other sleep medicines or sedatives (medicines that cause sleepiness), drink alcohol
or have a rare problem called succinic semialdehyde dehydrogenase deficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2525099d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Keep LUMRYZ in a safe place to prevent abuse and misuse. Selling or
giving away LUMRYZ may harm others and is against the law. Tell your doctor if you or your child have ever abused or been dependent on
alcohol, prescription medicines or street drugs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anyone who takes LUMRYZ should not do anything that requires them
to be fully awake or is dangerous, including driving a car, using heavy machinery or flying an airplane, for at least six (6)&nbsp;hours
after taking LUMRYZ. Those activities should not be done until you know how LUMRYZ affects you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Falling asleep quickly, including while standing or while getting
up from the bed, has led to falls with injuries that have required some people to be hospitalized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>LUMRYZ can cause serious side effects, including the following:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Breathing
                                            problems, including</B> slower breathing, trouble breathing and/or short periods of not breathing
                                            while sleeping (e.g., sleep apnea). People who already have breathing or lung problems have
                                            a higher chance of having breathing problems when they take LUMRYZ.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Mental
                                            health problems</B>, including confusion, seeing or hearing things that are not real (hallucinations),
                                            unusual or disturbing thoughts (abnormal thinking), feeling anxious or upset, depression,
                                            thoughts of killing yourself or trying to kill yourself, increased tiredness, feelings of
                                            guilt or worthlessness and difficulty concentrating. Tell your doctor if you or your child
                                            have or had depression or have tried to harm yourself. <B>Call your doctor right away if
                                            you or your child have symptoms of mental health problems or a change in weight or appetite.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Sleepwalking.
                                            </B>Sleepwalking can cause injuries. Call your doctor if you or your child start sleepwalking.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tell your doctor if you or your child are on a salt-restricted diet
or have high blood pressure, heart failure or kidney problems. LUMRYZ contains a lot of sodium (salt) and may not be right for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The most common side effects of LUMRYZ in adults include nausea, dizziness,
bedwetting, headache and vomiting. Your side effects may increase when you take higher doses of LUMRYZ. The most common side effects
in children include nausea, bedwetting, vomiting, headache, decreased weight, decreased appetite, dizziness, and sleepwalking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LUMRYZ can cause physical dependence and craving for the medicine
when it is not taken as directed. These are not all the possible side effects of LUMRYZ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For more information, ask your doctor or pharmacist. Call your
doctor for medical advice about side effects.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You are encouraged to report negative side effects of prescription
drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Please see full Prescribing Information, including BOXED Warning.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Avadel Pharmaceuticals plc</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company
focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications
that address the challenges patients face with current treatment options. Avadel&rsquo;s commercial product, LUMRYZ, was approved by
the U.S. Food&nbsp;&amp; Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or EDS
in patients 7 years of age and older with narcolepsy. For more information, please visit www.avadel.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2525099d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Avadel intends to use its Investor Relations website as a means of
disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors
should monitor the Company&rsquo;s Investor Relations website, in addition to following the Company&rsquo;s press releases, SEC filings,
public conference calls, presentations, and webcast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary Disclosure Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">This press release includes &ldquo;forward-looking
statements&rdquo; within the meaning of Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the Securities Exchange
Act of 1934. These forward-looking statements relate to our future expectations, beliefs, plans, strategies, objectives, results, conditions,
financial performance, prospects or other events. Such forward-looking statements include, but are not limited to, expectations regarding
the license agreement with XWPharma, including potential milestone and royalty payments; the potential therapeutic benefits of valiloxybate;
expectations about the development of valiloxybate, including timing of the pilot and pivotal PK and bioequivalence studies and potential
streamlined development pathway; the potential benefits of Avadel&rsquo;s existing infrastructure and commercial capabilities for the
development of valiloxybate; the Company&rsquo;s leadership in the field of sleep medicine and as an innovator in the treatment of sleep
disorders; the market position and growth of LUMRYZ; the importance of personalized care for individuals living with narcolepsy and IH;
expectations for the Company&rsquo;s pipeline; and the benefits of once-at-bedtime oxybate therapies. In some cases, forward-looking
statements can be identified by use of words such as &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;believe,&rdquo;
 &ldquo;expect,&rdquo; &ldquo;look forward,&rdquo; &ldquo;on track,&rdquo; &ldquo;guidance,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
 &ldquo;project,&rdquo; &ldquo;next steps&rdquo; and similar expressions and the negatives thereof (if applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Company&rsquo;s forward-looking statements
are based on estimates and assumptions that are made within the bounds of our knowledge of our business and operations and that we consider
reasonable. However, the Company&rsquo;s business and operations are subject to significant risks, and, as a result, there can be no
assurance that actual results and the results of the company&rsquo;s business and operations will not differ materially from the results
contemplated in such forward-looking statements. Factors that could cause actual results to differ from expectations in the Company&rsquo;s
forward-looking statements include the risks and uncertainties described in the &ldquo;Risk Factors&rdquo; section of Part&nbsp;I,&nbsp;Item
1A of the Company&rsquo;s most recent Annual Report on Form&nbsp;10-K and subsequent filings with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Forward-looking statements speak only as
of the date they are made and are not guarantees of future performance. Accordingly, you should not place undue reliance on forward-looking
statements. The Company does not undertake any obligation to publicly update or revise our forward-looking statements, except as required
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2525099d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About XWPharma</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">XWPharma is a clinical-stage, neuroscience-focused
biopharmaceutical company founded by a team of industry veterans who believe the hardest problems are the most important ones to solve.
Leveraging proprietary chemistry, proven drug development and commercialization expertise, and a commitment to reshaping antiquated treatment
paradigms in neuropsychiatry, XWPharma is advancing a pipeline of novel programs targeting clinically and commercially validated mechanisms,
each engineered in-house for best-in-class potential, high approvability, and durable IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Learn more at&nbsp;www.xwpharma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Austin Murtagh</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Precision AQ</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Austin.Murtagh@precisionAQ.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(212) 698-8696</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Alyssa Ramirez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Real Chemistry</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>aramirez@realchemistry.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>avdl-20250829.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa2NebOdzZR++YkxtmB6bdk6jyEtY0zUuSu4SRu2kSAE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:avdl="http://avadel.com/20250829" elementFormDefault="qualified" targetNamespace="http://avadel.com/20250829">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://avadel.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="avdl-20250829_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="avdl-20250829_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>avdl-20250829_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>avdl-20250829_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="avdl-20250829.xsd#Cover" roleURI="http://avadel.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://avadel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2525099d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2525099d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ *T# 2(  A$! Q$!_\0
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M,@R '*[6#[A_'K\2_'WB/XI>/M9\:^+KLW_B#Q?KLNJZM.A"L;[S0]MI\1
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M2&Q\*VWQ]TCXL:3\*O%VJ7,DAMK;PY$_Q(\":YJ/B%]D5CI&H7&I.VR)G/\
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LO>]WJ]5U;_ DHHHJR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 29,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVADEL PHARMACEUTICALS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001012477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1341933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10
        Earlsfort Terrace<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02
T380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1
901-5201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary
Shares, nominal value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVDL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2525099d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://avadel.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>avdl-20250829.xsd</File>
    <File>avdl-20250829_lab.xml</File>
    <File>avdl-20250829_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2525099d1_8k.htm">tm2525099d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2525099d1_8k.htm": {
   "nsprefix": "avdl",
   "nsuri": "http://avadel.com/20250829",
   "dts": {
    "schema": {
     "local": [
      "avdl-20250829.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "avdl-20250829_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avdl-20250829_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2525099d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://avadel.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2525099d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2525099d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://avadel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-25-087076-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-087076-xbrl.zip
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MJ]RQB_UFQ2F0?<JJ<@5!AT7-@442! JP+Y.&&XY**2JT/K)3-<Q:FF.4NP+
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MT^;;E#9M0 AU&@3?GZQB5*H8K)GREC)&S.12:\T[GA(W5.X3Q[0LMG/'5)*
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MPI_H0JH*\(=*(.\_,'F7>4/"_'=*5$(5WT!(GXB!L-]@PG8X1.(]5D1H9OE
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M:KY4SI?78Y/D/:8G)H+OA;YS=^\\F_F*%LXSMSE)3+&Y2[V(X@:;(7>X)C3
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MH$D:I\?'K7:[=7KR%E!\H]X XDS?@?%[A4:!E$O5M:U77_DM]O2Q\B+D@M#
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MJ9SI5#9+]Z0B4NU$6H;H20IKA\PJ0YFL> %%)D0L- '=%Y9I,?F)XY.ZZUH
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MY==6](>QJ.J;SJ*O$_0LSHMLQ-W59];:/3GZBGDVTC]G' *M.)55T6M&$XI
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M\P4>%;A;T8N$TV)2[U>CH"04!FY]1^1(@J'@<"5>RSU&E ^T*XF;.? 52\Z
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MOBC!A$O@#S*PMKIS24\"(?,1"HYWRYIXD2,-A,\$QFRJ%%%;4JPNZ,L%0<;
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M6>];^Z>'[U%#O/7Z\LW)R_\#4$L! A0#%     @ (84C6P_J]MXH P  W L
M !$              ( !     &%V9&PM,C R-3 X,CDN>'-D4$L! A0#%
M  @ (84C6WRC3L#]"@  ?X8  !4              ( !5P,  &%V9&PM,C R
M-3 X,CE?;&%B+GAM;%!+ 0(4 Q0    ( "&%(UN.<HNF6 <  -!7   5
M          "  8<.  !A=F1L+3(P,C4P.#(Y7W!R92YX;6Q02P$"% ,4
M"  AA2-;#!4MF](:   #A   $@              @ $2%@  =&TR-3(U,#DY
M9#%?.&LN:'1M4$L! A0#%     @ (84C6Z6QY581'@  FH,  !8
M     ( !%#$  '1M,C4R-3 Y.60Q7V5X.3DM,2YH=&U02P4&      4 !0!)
) 0  64\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2525099d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avdl-20250829.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-29" id="Fact000004">0001012477</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-08-29" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-29" id="Fact000011">2025-08-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-29" id="Fact000012">AVADEL PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-29" id="Fact000013">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-29" id="Fact000014">001-37977</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-29" id="Fact000015">98-1341933</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-29" id="Fact000016">10         Earlsfort Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-29" id="Fact000017">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="AsOf2025-08-29" id="Fact000018">IE</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-29" id="Fact000019">D02 T380</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-29" id="Fact000020">353</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-29" id="Fact000021">1 901-5201</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-29" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-29" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-29" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-29" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-08-29" id="Fact000026">Ordinary Shares, nominal value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-08-29" id="Fact000027">AVDL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-08-29" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-29" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
